Sign in

ESGREV

@esgrev-escmid.bsky.social
139 followers 188 following 11 posts

ESCMID Study Group for Respiratory Viruses

PostsRepliesMedia
Reposted by ESGREV
ImmunizeCanada @immunizecanada.bsky.social · 27/06/2026
Protégez votre enfant contre la maladie à méningocoque | immunize.ca/sites/default/f... #méningococcie #LesVaccinsÇaMarche #LesVaccinsSauventDesVies #FaitesVousVacciner
001
Reposted by ESGREV
Open Forum Infectious Diseases @ofidjournal.bsky.social · 28/06/2026
Defining Success And Failure In Prosthetic Joint Infections: A Meta-Epidemiologic Study Towards A Core Outcome Set ✅ Just Accepted 🔗 bit.ly/4vuW8JP
133
Reposted by ESGREV
The Journal of Infectious Diseases @jidjournal.bsky.social · 09/06/2026
What is the optimal RSV immunisation strategy for infants born in the RSV off-season? ✅ Just Accepted 🔗 bit.ly/4ofctjd
154
Reposted by ESGREV
International Society for Infectious Diseases (ISID) @isid.org · 20/05/2026
🌍 From outbreak surveillance to education, research, and global collaboration, #ISID continues to support infectious disease professionals worldwide through a #OneHealth approach. 👉 Read more in this feature from touchINFECTIOUS DISEASES: ow.ly/70K950Z1caE
111
ESGREV @esgrev-escmid.bsky.social · 20/05/2026
👇
000
Reposted by ESGREV
European Centre for Disease Prevention and Control @ecdc.europa.eu · 19/05/2026
Ebola virus disease outbreak in the Democratic Republic of the Congo - ECDC update - 19 May 2026. A large outbreak of Bundibugyo ebolavirus disease is taking place in the Democratic Republic of the Congo (DRC). www.ecdc.europa.eu/en/ebola-vir... 🧵 #Ebola #Bundibugyo #PublicHealth #IdSky #EpiSky
ecdc.europa.eu
Ebola virus disease outbreak in the Democratic Republic of the Congo, 19 May 2026
On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) a Public Health Emergency of Inte...
12319
Reposted by ESGREV
Clinical Infectious Diseases @cidjournal.bsky.social · 19/05/2026
The latest CID supplement issue highlights new innovations in the infectious disease community. ↪️ bit.ly/3RaAStQ
131
Reposted by ESGREV
IDSA @idsainfo.bsky.social · 19/05/2026
In CID, authors developed a #measles transmission model for K-12 public schools in Texas at the school-district-level to estimate the potential risk and size of an unabated major measles outbreak among Texas schoolchildren. bit.ly/42NGWef
bit.ly
Risk of Measles Outbreak in Texas School Districts: A Modeling Study
Abstract. We developed a measles transmission model for K-12 public schools in Texas at the school-district-level. We found that, between 2025 and 2030, di
053
Reposted by ESGREV
Open Forum Infectious Diseases @ofidjournal.bsky.social · 02/05/2026
OFID is seeking research on expanding diagnostic, preventative, and therapeutic strategies to counter the impacts of AMR with a focus in low and middle income countries. Learn more and submit a proposal by June 28: bit.ly/3OGh1l1
002
Reposted by ESGREV
ESCMID @escmid.bsky.social · 02/05/2026
Developed in alignment with the WHO NPD Road Map 2030 and current global health priorities, this course combines high-level theoretical instruction with extensive hands-on training in a state-of-the-art reference laboratory. Learn more and register today. ow.ly/q5zI50YSrOo
032
Reposted by ESGREV
Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 02/05/2026
Catch up on all things 2025/2026 at the Hot Topics Session! Register now for the MAD-ID & SIDP 2026 Annual Meeting in Orlando, May 14–17 through the link in our bio!
012
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 20/04/2026
Even the ducks outside Messe München seem ready for tomorrow’s avian flu session 🦆 08:30 at #ESCMIDGlobal2026 | Hall ICM 13a with @escmid.bsky.social , @esgrev-escmid.bsky.social , @isrv.bsky.social, @isirvepi.bsky.social , @ecdc.europa.eu & @ema.europa.eu Early start—but worth it. 🔆
032
Reposted by ESGREV
esgvm.bsky.social @esgvm.bsky.social · 19/04/2026
FAO, UNEP, WHO and WOAH meet in Lyon for the Fourth Quadripartite Executive Annual Meeting to advance coordinated global action on One Health. Strengthening collaboration across human, animal, and environmental health is essential to address today’s complex challenges. For more info please see👇
fao.org
Strengthening One Health through coordinated action on implementation, science, policy and financing
Strengthening One Health through coordinated action on implementation, science, policy and financing
011
Reposted by ESGREV
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 14/04/2026
@esgrev-escmid.bsky.social Excited to take on this new challenge with this fantastic team and to contribute to the growth of ESGREV. See you all in Munich at #ESCMIDGlobal2026
032
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 24/03/2026
Prevention improves wellbeing 🌿 A 2024 Nature Medicine analysis shows that reducing infectious disease burden—through measures like vaccination, ventilation, and hygiene—has measurable benefits for population health & resilience. 🔗 www.nature.com/articles/s41... #Prevention #PublicHealth #VIVI
155
Reposted by ESGREV
Open Forum Infectious Diseases @ofidjournal.bsky.social · 05/03/2026
Epidemiology of HMPV and other respiratory viral infections among outpatients, 2016-2022 ✅ Just Accepted 🔗 bit.ly/4sneDhu
112
Reposted by ESGREV
Institut Pasteur | 130 years of biomedical research @pasteur.fr · 24/11/2025
🦠 Measles is back. Cases have exploded in 2025 in France, UK, US & Europe due to falling vaccine coverage. The MMR vaccine is ~100% effective with 2 doses. It's saved 94M lives since 1974. Measles isn't just for kids – 34% of US cases were adults over 20. www.pasteur.fr/en/research-... #Measles
pasteur.fr
Three questions about measles: why is it on the rise, is the vaccine effective, and can you catch it at any age?
A few years ago, measles seemed to be on the verge of being eradicated in many countries. The recent rise in cases raises several questions. Why is measles making a comeback? Is the measles, mumps and...
0137
Reposted by ESGREV
International Society of Antimicrobial Chemotherapy @isacworld.bsky.social · 24/11/2025
🌍 World AMR Awareness Week (#WAAW2025) 🎥 Dr Teske Schoffelen introduces the Abx Guide—a free, open-access database that compiles evidence on pathogen-directed antibiotic treatment. ▶️ Watch: youtu.be/XpN_fRG7pCk @heiman-wertheim.bsky.social @souhakanj.bsky.social
youtu.be
WAAW 2025 | ISAC Abx Guide
YouTube video by ISAC / APUA
033
Reposted by ESGREV
European Centre for Disease Prevention and Control @ecdc.europa.eu · 17/11/2025
DON'T MISS IT! From Resistance to Resilience: healthcare workers leading the change. Join public health professionals, academia, patients' and NGO's representatives and let's talk about the ways to #KeepAntibioticsWorking! #EAAD2025 online event starts at 1PM CET! Register: bit.ly/EAAD2025Regi...
148
Reposted by ESGREV
Eurosurveillance journal @eurosurveillance.org · 14/11/2025
#Respiratory syncytial virus can cause severe illness especially in infants Data from Belgium, Portugal & Spain show that #immunisation of #children after birth with long-acting monoclonal antibodies 📉 the risk of #hospitalisation due to #RSV infection by ~80% #IDSky #EpiSky #PedSky #MedSky 🛟🧪
eurekalert.org
Study in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants
Respiratory syncytial virus can cause severe illness especially in young infants. A new study published in Eurosurveillance shows that immunisation of children after birth reduced the risk of hospital...
085
Reposted by ESGREV
European Centre for Disease Prevention and Control @ecdc.europa.eu · 13/11/2025
You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language! Check it out here: vaccination-info.europa.eu/en/rsv #UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
vaccination-info.europa.eu
RSV
Key facts on RSV symptoms, complications, risk factors, how it spreads, prevention, vaccination and treatment.
035
Reposted by ESGREV
European Centre for Disease Prevention and Control @ecdc.europa.eu · 13/11/2025
This winter, raising awareness among healthcare workers & following national recommendations will remain essential to reducing the burden of RSV on infants. Press release: bit.ly/4qSWLex Rapid scientific advice: bit.ly/4hTTNSG Living systematic review: bit.ly/4hVQLxz #IDsky #EpiSky
bit.ly
Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued a rapid scientific advice on effective ways to mitigate the impact of RSV disease in infants through immunisation interventions.
155
ESGREV @esgrev-escmid.bsky.social · 09/11/2025
🛎️
000
Reposted by ESGREV
Zentrum für Klinische Studien (ZKS) Köln @zks-koeln.bsky.social · 06/11/2025
🎓 Jetzt anmelden! Vom 01.–05.12.2025 bietet die Akademie des ZKS Köln wieder den Kurs für Studienkoordination an – als virtuelle Präsenzschulung. Für Study Nurses & Interessierte, die ins Studienmanagement einsteigen wollen. 👉 zks.uni-koeln.de/akademie/kurs-fuer-studienkoordination
023
Reposted by ESGREV
ESWI @eswinfluenza.bsky.social · 23/10/2025
📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics A fascinating look at how science reshaped our view of disease and response🧠 #PublicHealth #Pandemic #History
063
Reposted by ESGREV
IDWeek @idweek.bsky.social · 20/10/2025
Immunization against respiratory syncytial virus delivered to infants following birth is safe and provides high antibody levels, regardless of the mother’s RSV vaccination status, according to new research presented at #IDWeek2025. bit.ly/3J9fIbS
bit.ly
RSV Immunization in Infants Is Safe and Provides High Antibody Levels Regardless of Mother’s Vaccination Status
074
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 19/10/2025
✈️ Next stop: #ESWI2025 in Valencia! We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation. Looking forward to sharing insights, forging collaborations, and advancing prevention together. #VIVI #InfectionPrevention
145
Reposted by ESGREV
Critical Care Reviews @criticalcarereviews.com · 13/10/2025
➡️ Pediatric myocarditis is more often viral and acute, adults more chronic and immune-mediated ➡️ Diagnosis and treatment draw from adult data, leaving major gaps in paediatric evidence CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evide...
002
Reposted by ESGREV
Trainee Association of ESCMID @taescmid.bsky.social · 09/10/2025
There are a few days left to apply for an ESCMID observership! ESCMID is awarding 50 young scientists up to 2K EUR to travel to one of the over 100 collaborative centres for knowledge exchange in the fields of CM & ID! Read more and apply before the deadline on Tuesday, 14 October: ow.ly/95BK50X2GRP
001
Reposted by ESGREV
Trainee Association of ESCMID @taescmid.bsky.social · 13/10/2025
📣🧊 The Trainee Association of ESCMID (TAE) is holding elections for 3 new members in the steering committee. Young Scientist Members (YSM) and LMIC members fulfilling the YSM criteria are eligible to apply. Nominations close 31 October. ow.ly/fHsy50X96Nb
001
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 24/09/2025
More than pills and shots — your gut microbiome might be a hidden key to vaccine success. 🌿 Recent research shows gut bacteria affect how well our bodies respond to #vaccines. Diet, probiotics, and microbiome health = new frontiers in prevention. #Microbiome #VIVI
123
Reposted by ESGREV
ESCMID @escmid.bsky.social · 11/09/2025
Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith. @ema.europa.eu #VaccinesConference #Vaccines #IDSky
043
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 12/09/2025
🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5). From surveillance to vaccines, global cooperation is key to staying ahead of future threats. Prevention today means resilience tomorrow. #UnitedInProtection 👉 bit.ly/ViVI-Prep2025
013
Reposted by ESGREV
Eurosurveillance journal @eurosurveillance.org · 11/09/2025
This week's rapid communications describe ➡️A strain of Neisseria gonorrhoeae producing false negative results on Xpert CT/NG assay in England 🔎An atypical sixfold rise in #influenza A(H1N1)pdm09 cases in Denmark during summer Full issue here 👉 bit.ly/eus2036 #EpiSky #IDSky #MedSky #STISky 🛟🦠🧫⚕️
Image showing the table of content of issue 36 in 2025:

Rapid communication
Detection and characterisation of Xpert CT/NG assay Neisseria gonorrhoeae diagnostic escape mutants, England, June 2025

An interseasonal outbreak of influenza A(H1N1)pdm09 related to a music festival, Denmark, August 2025

Research
Progress towards HIV transmission elimination targets: model-based estimation of incidence and the extent of undiagnosed infection, Scotland, 1981 to 2022

Repeated cross-sectional surveys show a decreasing trend in Borrelia burgdorferi sensu lato seroprevalence over a 50-year period, Finland, 1966 to 2017
196
Reposted by ESGREV
ImmunizeCanada @immunizecanada.bsky.social · 11/09/2025
#JeudiRétro | C’était la polio. Nous nous sommes fait vacciner. Éprouvés. Salvateurs. Les vaccins | www.immunize.ca/sites/defau... #polio #LesVaccinsÇaMarche #LesVaccinsSauventDesVies #FaitesVousVacciner
immunize.ca
001
Reposted by ESGREV
Harvard Epidemiology @harvardepi.bsky.social · 02/09/2025
Welcome back students! Joining us from 29 different countries hailing from 6 continents across the various degree programs are: 72 PhD students, 15 SM1 students, 13 SM1 summer-only students, 62 SM2 students, and 76 MPH Epi students in the Department of Epidemiology @hsph.harvard.edu.
Image of people walking down the stairs at the front of the Kresge building, Harvard T.H. Chan School of Public Health, Boston, MA. Welcome back sign.
044
Reposted by ESGREV
Open Forum Infectious Diseases @ofidjournal.bsky.social · 27/08/2025
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study ✅ Just Accepted #IDSky
bit.ly
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
112
Reposted by ESGREV
Critical Care Reviews @criticalcarereviews.com · 27/08/2025
Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evid…
011
Reposted by ESGREV
Open Forum Infectious Diseases @ofidjournal.bsky.social · 26/08/2025
Skin lesions and personal protective equipment (PPE) in healthcare workers from Lima, Peru during the COVID-19 pandemic: a cross-sectional study ✅ Just Accepted #IDSky
bit.ly
Skin lesions and personal protective equipment (PPE) in healthcare workers from Lima, Peru during the COVID-19 pandemic: a cross-sectional study
During the COVID-19 pandemic, healthcare workers (HCWs) relied on personal protective equipment (PPE) to mitigate COVID-19 infections.
001
Reposted by ESGREV
International Society of Antimicrobial Chemotherapy @isacworld.bsky.social · 25/08/2025
🧪 Just 1 week left to apply! ISAC Project Grants 2025 offer up to £15,000 for research in #AMR & #infectiousdiseases 🌍 Projects must involve 2 countries (1 LMIC) 📅 Deadline: 1 Sept 📧 secretariat@ISAC.world 🔗 isac.world #GlobalHealth #ISACGrants @heiman-wertheim.bsky.social @souhakanj.bsky.social
023
Reposted by ESGREV
Vaccine Safety Initiative @vaccinesafety.bsky.social · 25/08/2025
Stopping Spillover at the Source: #OneHealth Meets #Pandemic #Prevention 🛎️ A new roadmap in Emerging Infectious Diseases outlines how investigating and intercepting virus spillovers early—using integrated, cross‑sector efforts (One Health approach)—can help prevent future pandemics. #ActNow
A visual guide to One Health investigations of spillovers to assist with primary pandemic prevention. One Health investigations trace spillover events backward from detection, systematically uncovering the causal chain that led to spillover. This process involves characterizing the pathogen, contexts, and risks for transmission and determining the reservoir hosts and environmental conditions that enabled the event.
123
Reposted by ESGREV
The Journal of Infectious Diseases @jidjournal.bsky.social · 24/08/2025
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19 ✅ Just Accepted #IDSky
doi.org
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19
This letter iresponds to the recent meta-analysis reported by Mateja et al. (J Infect Dis. 2025 Jun 3: jiaf282), which supports the use of SARS-CoV-2 clearance as a surrogate for clinical benefit in COVID-19, and concludes that a single post-treatment nasopharyngeal swab is sufficient to assess...
112
Reposted by ESGREV
Critical Care Reviews @criticalcarereviews.com · 24/08/2025
The 715th Critical Care Reviews Newsletter is now out, covering the latest critical care publications from across the literature over the past week. Sample issue - criticalcarereviews.com/newsletters… Subscribe at - criticalcarereviews.com/newsletters…
001
Reposted by ESGREV
Critical Care Reviews @criticalcarereviews.com · 17/08/2025
Advances in ischemic stroke treatment: current and future therapies CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evid…
011
Reposted by ESGREV
ESGPHM @esgphm.bsky.social · 02/07/2025
www.escmid-foundation.org/event-detail... We are pleased to announce this Postgraduate Course co-organised by: @escmid.bsky.social , #EIS, #ESGCIP, #ESGMD, #ESGIE, @esgphm.bsky.social, #EVASG, @esgrev-escmid.bsky.social and the #BIA; Sevilla, Spain, 21-23/10/25. Registration will close July 15.
escmid-foundation.org
Emerging Infectious Diseases: Understanding, Prevention, and Response
001
ESGREV @esgrev-escmid.bsky.social · 15/04/2025
Stay tuned for the next @ESCMID event! If you are working in vaccines and don’t want to wait until ESCMIDGlobal 2026 in Munich, then check out this vaccine conference in Lisbon in the fall this year.
011
Reposted by ESGREV
ImmunizeCanada @immunizecanada.bsky.social · 15/04/2025
Allez voir l’infographie créée par Immunisation Canada! | Les vaccins contre la coqueluche durant la #grossesse | immunize.ca/sites/defaul... #coqueluche #LesVaccinsÇaMarche #FaitesVousVacciner
012
Reposted by ESGREV
ESCMID @escmid.bsky.social · 15/04/2025
The congress may be ending today but the content can be revisited in our #ESCMIDGlobal replay section. All scientific sessions can be watched or rewatched on the virtual congress platform available for 6 months: ow.ly/f6fP50VzPeU
173
Reposted by ESGREV
ESCMID @escmid.bsky.social · 15/04/2025
Last chance at the Vienna Opera House-themed photobooth this year! Create light-hearted moments with colleagues & friends dressed as classical musicians on stage using a variety of entertaining props. #ESCMIDGlobal #IDSky #clinmicro
041